• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Denali Therapeutics Sees Positive Data in Trial for Enzyme Replacement Therapy

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 26, 2021 at 10:02: AM
via Denali Therapeutics Inc. said it saw positive interim data from a Phase 1/2 study evaluating DNL310, an investigational brain-penetrant enzyme replacement therapy intended to treat central nervous system and peripheral manifestations of Hunter syndrome.

article source
 




Top Bottom
Back
Quote